The inflammatory environment driven by relevant levels of endogenous IL-17 may promote tumor progression by stimulating angiogenesis; in contrast, overexpression of IL-17 may lead to inflammatory reactions that trigger cancer-cell destruction [31] and [35]. The gene discussed is IL17A; the disease is cancer.